Validation of the instrument “test your brain” for the elderly: iPad version

Francelise de Freitas, Eduardo Leal-Conceição, Mirna Wetters Portuguez

Abstract


AIMS: Validate the application for iPad (Apple, California, USA) “Teste seu Cérebro” as well as establish cutoff point between normal seniors and Mild Neurocognitive Impairment.
METHODS: In a prospective cross-sectional study, elderly subjects who attended the neuropsychology clinic of a tertiary health hospital in the southern region of Brazil and the community in general underwent cognitive assessment using two instruments: the Montreal Cognitive Assessment (Gold Standard Test) and the “Teste seu Cérebro”. These results served as a parameter to validate the said application from a diagnostic test and to establish the cutoff point between normal elderly and mild cognitive impairment; the following statistical measures were determined: sensitivity and specificity, internal consistency and reliability reached by the McDonald’s Omega coefficient and Pearson’s correlation coefficient, respectively. The average “Teste seu Cérebro” cutoff point to detect cases classified as mild neurocognitive impairment by the Montreal Cognitive Assessment was obtained through the ROC curve. Evaluations include functions such as memory, attention / orientation, fluency, language, and visuospatial skills.                                                                                                RESULTS: The sample consisted of 104 participants with mean age of 70.3 (standard deviation = 6.6), with a minimum age of 60 and a maximum of 87 years. An acceptable reliability was achieved for the “Teste seu Cérebro” application by analyzing the internal consistency. In the comparison between the general scores of the two instruments (Teste seu Cérebro and Montreal Cognitive Assessment), where the result showed a statistically significant correlation, positive and classified as moderate. The cutoff point of the “Teste seu Cérebro” scores that best discriminated patients with mild neurocognitive impairment diagnosed by the Montreal Cognitive Assessment was 89.5%, that is, scores below or equal to that percentage reached higher sensitivity and specificity for the instrument. No influence of sociodemographic variables such as sex, age and schooling were identified on the linearity relationship between the “Teste seu Cérebro” and Montreal Cognitive Assessment instruments. CONCLUSIONS: The results suggest that the “Teste seu Cérebro” instrument can be safely used to identify early and accurately the presence of Mild Neurocognitive Impairment in the elderly population. New studies will be directed to the validation of the instrument “Teste seu Cérebro” in the identification of other types of cognitive disorders, in addition to Mild Neurocognitive Impairment.


Keywords


Elderly; cognition; App; validation.

References


Malloy-Diniz LF, Fuentes D, Cosenza RM. Neuropsicologia do envelhecimento: uma abordagem multidimensional. Porto Alegre: Artmed; 2013.

Rabelo DF. Declínio cognitivo leve em idosos: fatores associados, avaliação e intervenção. Rev Min Ciênc Saúde. 2009;1(1):56-68.

Hunter CL, Goodie JL, Oordt MS, Dobmeyer AC, editors. Integrated behavioral health in primary care: Step-by-step guidance for assessment and intervention. Washington, DC: American Psychological Association; 2017. https://doi.org/10.1037/0000017-000

Memória CM, Yassuda SM, Nakano EY, Forlenza VO. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry. 2013;2:34-40. https://doi.org/10.1002/gps.3787

Yassuda MS. Em: Freitas EV, Neri AN, Cançado FAX, Gorzoni ML, Rocha SM, editores. Tratado de geriatria e gerontologia. Rio de Janeiro: Guanabara Koogan; 2006. p. 914-20.

Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98. https://doi.org/10.1016/0022-3956(75)90026-6

Pires EC. Avaliação de testes complementares para diagnósticos médicos: uma contribuição estatística [dissertação]. [Belo Horizonte]: Universidade Federal de Minas Gerais; 2003.

Goveas J, Xie C, Wu Z, Douglas WB, Li W, Franczak MB, Jones JL, Antuono PG, Yang Z, Li SJ. Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study. Behavioural Brain Res. 2011;219(2):205-12. https://doi.org/10.1016/j.bbr.2011.01.008

ALVES, Tânia Corrêa de Toledo Ferraz; WAJNGARTEN, Mauricio; BUSATTO FILHO, Geraldo. Fatores de risco cardiovascular, declínio cognitivo e alterações cerebrais detectadas através de técnicas de neuroimagem. Arch Clin Psychiatr. 2005;32(3)160-9. https://doi.org/10.1590/S0101-60832005000300008

Pasquali L. Psicometria: Teoria dos testes na Psicologia e na Educação. Petrópolis: Editora Vozes; 2003.

Campo-Arias A, Villamil-Vargas M, Herazo E. Confiabilidad y dimensionalidad del audit en estudiantes de medicina. Reliability and dimensionality of the AUDIT in medical students. Psicol Caribe. 2013;30(1):21-35.

Mukaka MM. A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012; 24(3):69-71.

Fawcett T. An introduction to ROC analysis. Pattern Recog Lett. 2006;27(8):861-74. https://doi.org/10.1016/j.patrec.2005.10.010

Cavalcante ES, Miranda FAN, Nicolete MGP, Santos RA, Barbosa SJC, Cavalcante RCGA, Santos E. Caracterização do idoso atendido numa UBSF em Campina Grande, PB. Inter Sci Place. 2010; 1(11):e12.

Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K, Ciesielska N. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr. Pol. 2016;50: 1039-52. https://doi.org/10.12740/PP/45368




DOI: http://dx.doi.org/10.15448/1980-6108.2019.4.32973

e-ISSN: 1980-6108 | ISSN-L: 1806-5562


Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.